{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:08:18Z","timestamp":1787501298068,"version":"build-2736575974"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"publisher","award":["JP 23K16252"],"award-info":[{"award-number":["JP 23K16252"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cryptococcosis is a notable infectious complication of liver transplantation. Currently, there is no recommendation for screening serum cryptococcal antigen (CrAg) levels in solid organ transplant recipients. We aimed to explore the role of serum CrAg in liver transplant recipients at an institution where posttransplant serum CrAg has been widely tested.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study was conducted at a tertiary care center in Japan. All liver transplant recipients with serum CrAg measured either for screening or for diagnostic testing at least once after transplantation between April 2005 and March 2022 were included. For participants with either a positive CrAg test result or positive culture for Cryptococcus, we manually reviewed clinical manifestations, management, and prognosis from the medical records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During the study period, 12 885 serum CrAg tests (median, 16 tests per patient) were performed in 468 liver transplant recipients. The 1-year posttransplant incidence of positive serum CrAg test results and culture-proven cryptococcosis was 1.9% (9\/468) and 0.6% (3\/468), respectively. No patient with persistently negative serum CrAg test results showed growth of Cryptococcus in culture. Four patients had clinical manifestations consistent with cryptococcosis, of whom 2 (50.0%) started antifungal therapy promptly based on a positive serum CrAg test result. In contrast, 5 patients had no clinical manifestations. Three of the 5 (60.0%) patients did not receive antifungal therapy and remained free of clinical manifestations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Serum CrAg test was more sensitive than culture among liver transplant recipients and prompted early diagnosis and antifungal therapy in symptomatic patients. However, serial screening of serum CrAg in asymptomatic patients may be of little value, with the potential for false-positive results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofae255","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T08:35:48Z","timestamp":1715848548000},"source":"Crossref","is-referenced-by-count":8,"title":["The Role of Frequent Screening or Diagnostic Testing of Serum Cryptococcal Antigen in Liver Transplant Recipients: A Descriptive Epidemiology"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1630-1313","authenticated-orcid":false,"given":"Toshiki","family":"Miwa","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, The University of Tokyo Hospital , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4072-9096","authenticated-orcid":false,"given":"Koh","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The University of Tokyo Hospital , Tokyo , Japan"},{"name":"Department of Infectious Diseases, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Ikeuchi","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The University of Tokyo Hospital , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The University of Tokyo Hospital , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Okugawa","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The University of Tokyo Hospital , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Ichida","sequence":"additional","affiliation":[{"name":"Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Akamatsu","sequence":"additional","affiliation":[{"name":"Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeya","family":"Tsutsumi","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The University of Tokyo Hospital , Tokyo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,17]]},"reference":[{"key":"2024053113413220200_ofae255-B1","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1086\/598936","article-title":"Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: evidence-based evolving trends","volume":"48","author":"Sun","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2024053113413220200_ofae255-B2","first-page":"1122","article-title":"Long-term mortality and disability in cryptococcal meningitis: a systematic literature review","volume":"66","author":"Pasquier","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2024053113413220200_ofae255-B3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/cid\/cix867","article-title":"Comparative epidemiology and outcomes of human immunodeficiency virus (HIV), non-HIV non-transplant, and solid organ transplant associated cryptococcosis: a population-based study","volume":"66","author":"George","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2024053113413220200_ofae255-B4","doi-asserted-by":"crossref","first-page":"100563","DOI":"10.1016\/j.eclinm.2020.100563","article-title":"Potential missed opportunities for diagnosis of cryptococcosis and the association with mortality: a cohort study","volume":"27","author":"Salazar","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2024053113413220200_ofae255-B5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.amjmed.2019.04.026","article-title":"Presentation and mortality of cryptococcal infection varies by predisposing illness: a retrospective cohort study","volume":"132","author":"Hevey","year":"2019","journal-title":"Am J Med"},{"key":"2024053113413220200_ofae255-B6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/cid\/ciz193","article-title":"A multicenter, longitudinal cohort study of cryptococcosis in human immunodeficiency virus\u2013negative people in the United States","volume":"70","author":"Marr","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024053113413220200_ofae255-B7","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/cid\/ciad321","article-title":"Current epidemiology and clinical features of Cryptococcus infection in patients without human immunodeficiency virus: a multicenter study in 46 hospitals in Australia and New Zealand","volume":"77","author":"Coussement","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2024053113413220200_ofae255-B8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/jof7070524","article-title":"Fungal infections in liver transplant recipients","volume":"7","author":"Scolarici","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2024053113413220200_ofae255-B9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1399-3062.2002.t01-1-02005.x","article-title":"Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients","volume":"4","author":"Wu","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"2024053113413220200_ofae255-B10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00029330-200804010-00010","article-title":"Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation","volume":"121","author":"Shi","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"2024053113413220200_ofae255-B11","doi-asserted-by":"crossref","first-page":"e13361","DOI":"10.1111\/tid.13361","article-title":"Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center","volume":"22","author":"Lum","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"2024053113413220200_ofae255-B12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.12659\/AOT.881989","article-title":"Invasive fungal infections following liver transplantation\u2014risk factors, incidence and outcome","volume":"16","author":"Pacholczyk","year":"2011","journal-title":"Ann Transplant"},{"key":"2024053113413220200_ofae255-B13","first-page":"110","article-title":"Invasive fungal infections in liver transplant recipients","volume":"12","author":"Ok At\u0131lgan","year":"2014","journal-title":"Exp Clin Transplant"},{"key":"2024053113413220200_ofae255-B14","doi-asserted-by":"crossref","first-page":"ofx004","DOI":"10.1093\/ofid\/ofx004","article-title":"Epidemiology of cryptococcosis and cryptococcal meningitis in a large retrospective cohort of patients after solid organ transplantation","volume":"4","author":"George","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2024053113413220200_ofae255-B15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/511438","article-title":"Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality","volume":"195","author":"Singh","year":"2007","journal-title":"J Infect Dis"},{"key":"2024053113413220200_ofae255-B16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1399-3062.2005.00072.x","article-title":"Cryptococcosis after living donor liver transplantation: report of three cases","volume":"7","author":"Akamatsu","year":"2005","journal-title":"Transpl Infect Dis"},{"key":"2024053113413220200_ofae255-B17","doi-asserted-by":"crossref","first-page":"ofac253","DOI":"10.1093\/ofid\/ofac253","article-title":"Testing for cryptococcosis at a major commercial laboratory\u2014United States, 2019-2021","volume":"9","author":"Benedict","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2024053113413220200_ofae255-B18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/cid\/ciy567","article-title":"Impact of routine cryptococcal antigen screening and targeted preemptive fluconazole therapy in antiretroviral-naive human immunodeficiency virus\u2013infected adults with CD4 cell counts &lt;100\/\u03bcL: a systematic review and meta-analysis","volume":"68","author":"Temfack","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024053113413220200_ofae255-B19","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2024053113413220200_ofae255-B20","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/cid\/ciac675","article-title":"Cryptococcal antigenemia in advanced human immunodeficiency virus disease: pathophysiology, epidemiology, and clinical implications","volume":"76","author":"Wake","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2024053113413220200_ofae255-B21","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1093\/ofid\/ofx162.128","article-title":"Routine cryptococcal antigen screening in solid organ transplant recipients: is it time to save lives and money?","volume":"4","author":"George","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2024053113413220200_ofae255-B22","doi-asserted-by":"crossref","first-page":"e13543","DOI":"10.1111\/ctr.13543","article-title":"Cryptococcosis in solid organ transplantation\u2014guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Baddley","year":"2019","journal-title":"Clin Transplant"},{"key":"2024053113413220200_ofae255-B23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/ajt.12520","article-title":"Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study","volume":"14","author":"Egawa","year":"2014","journal-title":"Am J Transplant"},{"key":"2024053113413220200_ofae255-B24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2024053113413220200_ofae255-B25","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) consensus group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2024053113413220200_ofae255-B26","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/cid\/cix872","article-title":"High cryptococcal antigen titers in blood are predictive of subclinical cryptococcal meningitis among human immunodeficiency virus\u2013infected patients","volume":"66","author":"Wake","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2024053113413220200_ofae255-B27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-3156.2007.01874.x","article-title":"Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda","volume":"12","author":"Liechty","year":"2007","journal-title":"Trop Med Int Health"},{"key":"2024053113413220200_ofae255-B28","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial","volume":"385","author":"Mfinanga","year":"2015","journal-title":"Lancet"},{"key":"2024053113413220200_ofae255-B29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.idc.2006.07.001","article-title":"Cryptococcosis","volume":"20","author":"Chayakulkeeree","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"2024053113413220200_ofae255-B30","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2024053113413220200_ofae255-B31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3201\/eid0703.017302","article-title":"Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome","volume":"7","author":"Husain","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"2024053113413220200_ofae255-B32","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0040021","article-title":"Determinants of disease presentation and outcome during cryptococcosis: the CryptoA\/D study","volume":"4","author":"Dromer","year":"2007","journal-title":"PLoS Med"},{"key":"2024053113413220200_ofae255-B33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11046-023-00814-1","article-title":"Trends in the incidence of disseminated cryptococcosis in Japan: a nationwide observational study, 2015\u20132021","volume":"189","author":"Akazawa","year":"2024","journal-title":"Mycopathologia"},{"key":"2024053113413220200_ofae255-B34","doi-asserted-by":"crossref","first-page":"e01238-18","DOI":"10.1128\/JCM.01238-18","article-title":"Cryptococcal meningitis diagnostics and screening in the era of point-of-care laboratory testing","volume":"57","author":"Rajasingham","year":"2019","journal-title":"J Clin Microbiol"},{"key":"2024053113413220200_ofae255-B35","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/clinids\/23.4.827","article-title":"Serum cryptococcal antigen in patients with AIDS","volume":"23","author":"Feldmesser","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2024053113413220200_ofae255-B36","doi-asserted-by":"crossref","first-page":"e01648-19","DOI":"10.1128\/JCM.01648-19","article-title":"Clinical significance of low Serum cryptococcal antigen titers by lateral flow assay in immunocompromised patients: a retrospective case-control study","volume":"58","author":"Dizon","year":"2020","journal-title":"J Clin Microbiol"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae255\/57727231\/ofae255.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/5\/ofae255\/57978486\/ofae255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/5\/ofae255\/57978486\/ofae255.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T17:49:13Z","timestamp":1717177753000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae255\/7675980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,4,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae255","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,4,26]]},"article-number":"ofae255"}}